JP2023547770A5 - - Google Patents

Info

Publication number
JP2023547770A5
JP2023547770A5 JP2023518997A JP2023518997A JP2023547770A5 JP 2023547770 A5 JP2023547770 A5 JP 2023547770A5 JP 2023518997 A JP2023518997 A JP 2023518997A JP 2023518997 A JP2023518997 A JP 2023518997A JP 2023547770 A5 JP2023547770 A5 JP 2023547770A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
disease
acceptable salt
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023518997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023547770A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052074 external-priority patent/WO2022067114A1/en
Publication of JP2023547770A publication Critical patent/JP2023547770A/ja
Publication of JP2023547770A5 publication Critical patent/JP2023547770A5/ja
Pending legal-status Critical Current

Links

JP2023518997A 2020-09-25 2021-09-24 Tlrシグナル伝達の調節剤としての化合物及び組成物 Pending JP2023547770A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063083685P 2020-09-25 2020-09-25
US63/083,685 2020-09-25
PCT/US2021/052074 WO2022067114A1 (en) 2020-09-25 2021-09-24 Compounds and compositions as modulators of tlr signaling

Publications (2)

Publication Number Publication Date
JP2023547770A JP2023547770A (ja) 2023-11-14
JP2023547770A5 true JP2023547770A5 (https=) 2024-10-22

Family

ID=78650032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518997A Pending JP2023547770A (ja) 2020-09-25 2021-09-24 Tlrシグナル伝達の調節剤としての化合物及び組成物

Country Status (16)

Country Link
US (1) US20240043395A1 (https=)
EP (1) EP4217342A1 (https=)
JP (1) JP2023547770A (https=)
KR (1) KR20230074744A (https=)
CN (1) CN116507607A (https=)
AR (1) AR123604A1 (https=)
AU (1) AU2021347364A1 (https=)
CA (1) CA3193577A1 (https=)
CL (1) CL2023000853A1 (https=)
CO (1) CO2023005057A2 (https=)
CR (1) CR20230177A (https=)
IL (1) IL301574A (https=)
MX (1) MX2023003348A (https=)
PE (1) PE20231209A1 (https=)
TW (1) TW202229249A (https=)
WO (1) WO2022067114A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024008868A (es) 2022-01-18 2024-09-23 Maze Therapeutics Inc Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso.
WO2024015761A2 (en) * 2022-07-11 2024-01-18 Rutgers, The State University Of New Jersey Gαlpha12 inhibitors and methods using same
KR20250091305A (ko) * 2022-11-10 2025-06-20 프라임 진 테라퓨틱스 컴퍼니 리미티드 질소 함유 스피로 고리 화합물, 약학 조성물 및 이의 용도
PY2404093A (es) * 2023-01-30 2024-10-03 Eurofarma Laboratorios S A Hidrazidas bloqueadoras de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de los mismos y kits
CN116425698B (zh) * 2023-06-15 2023-08-29 广东省科学院微生物研究所(广东省微生物分析检测中心) 甲基噻唑类化合物及其制备方法和应用
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
CN118994047B (zh) * 2024-08-13 2026-02-10 中国药科大学 一种水杨醛衍生物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
PT1607390E (pt) 2003-03-25 2010-10-12 Sumitomo Chemical Co Composto de pirazole
JP2006199941A (ja) * 2004-12-20 2006-08-03 Chisso Corp クロマン環を有する化合物を含有する液晶組成物
EA202092305A1 (ru) * 2018-03-27 2020-12-07 Нейропор Терапиз, Инк. Соединения в качестве модуляторов сигнализации tlr2
AU2020245489A1 (en) * 2019-03-26 2021-10-14 Neuropore Therapies, Inc. Compounds and compositions as modulators of tlr signaling

Similar Documents

Publication Publication Date Title
JP2023547770A5 (https=)
JP2019508407A5 (https=)
JP2024166311A (ja) 化合物、組成物、及び、方法
JP2024086819A (ja) 化合物、組成物、及び、方法
JP2009114202A (ja) ホスフォノセフェム誘導体、その製造法および用途
DK161024B (da) Analogifremgangsmaade til fremstilling af cephalosporinderivater
JP2014523901A5 (https=)
JP2022544714A5 (https=)
CH630923A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
JP2010509342A5 (https=)
JPH0314039B2 (https=)
JP2007522142A5 (https=)
JP2022527294A5 (https=)
JPH0333712B2 (https=)
JP2025509635A5 (https=)
NL8300755A (nl) Chemische verbindingen.
DE69028342T2 (de) Cephalosporinverbindungen und Verfahren zu ihrer Herstellung
NO793688L (no) Fremgangsmaate ved fremstilling av cephalosporinderivater
JP2025514802A5 (https=)
DE69132580T2 (de) 7-Acyl-3-(substituierte carbamoyloxy) Cephem Verbindungen, Verfahren zu ihrer Herstellung und Anwendung
CH651574A5 (de) Cephalosporinantibiotika, ihre herstellung und pharmazeutische zubereitungen.
JPH0461000B2 (https=)
JPS6310792A (ja) 新規セフエム化合物
JP2024540937A (ja) Lpa受容体活性に関連する状態を処置するための化合物および組成物
DE3784778T2 (de) Cephemverbindungen, ihre herstellung und anwendung.